A POPULATION-BASED STUDY OF TUBERCULOSIS INCIDENCE AMONG RHEUMATIC DISEASE PATIENTS UNDER ANTI-TNF TREATMENT

被引：0
|
作者：
Sartori, Natalia [1 ]
Chakr, Rafael [1 ]
Papke, Afonso [1 ]
Picon, Paulo [2 ]
Neyeloff, Jeruza [3 ]
机构：
[1] Hosp Clin Porto Alegre, Dept Rheumatol, Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Dept Internal Med, Porto Alegre, RS, Brazil
[3] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.3740
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0632
引用
下载
收藏
页码：610 / 610
页数：1
相关论文
共 50 条
  • [31] Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFα
    Hanta, Ismail
    Ozbek, Suleyman
    Kuleci, Sedat
    Sert, Murat
    Kocabas, Ali
    CLINICAL RHEUMATOLOGY, 2007, 26 (11) : 1867 - 1870
  • [32] Anti-TNFα treatment during pregnancy and birth outcomes -: A population based study
    Kieler, Helle
    Granath, Fredrik
    Fored, Michael
    Stephansson, Olof
    Norgaard, Mette
    Pedersen, Lars
    Keenan, Greg
    Chavers, Scott
    Rahman, Mirza
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S226 - S226
  • [33] Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis
    Targownik, Laura E.
    Tennakoon, Aruni
    Leung, Stella
    Lix, Lisa M.
    Nugent, Zoann
    Singh, Harminder
    Bernstein, Charles N.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (03) : 409 - 420
  • [34] Impact of Anti-TNF on the Prevalence of Hepatobiliary and Pancreatic Disorders Associated With Inflammatory Bowel Disease: A Population-Based Study
    Hamid, Osama
    Alchirazi, Khaled Alsabbagh
    Eltelbany, Ahmed
    Nanah, Rama
    Mohammed, Abdul
    Regueiro, Miguel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S663 - S664
  • [35] Impact of early anti-TNF use on clinical outcomes in Crohn's disease: a nationwide population-based study
    Jung, Yoon Suk
    Han, Minkyung
    Park, Sohee
    Cheon, Jae Hee
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (05): : 1104 - +
  • [36] A negative screening does not eliminate tuberculosis risk under anti-TNF treatment in inflammatory bowel disease: a descriptive study
    Abitbol, Y.
    Laharie, D.
    Cosnes, J.
    Allez, M.
    Nancey, S.
    Amiot, A.
    Aubourg, A.
    Fumery, M.
    Altwegg, R.
    Michetti, P.
    Chanteloup, E.
    Seksik, P.
    Abitbol, V.
    Baudry, C.
    Flamant, M.
    Bouguen, G.
    Stefanescu, C.
    Bourrier, A.
    Bommelaer, G.
    Dib, N.
    Bigard, M. A.
    Viennot, S.
    Hebuterne, X.
    Gornet, J. M.
    Marteau, P.
    Bouhnik, Y.
    Nahon, S.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S382 - S382
  • [37] A Negative Screening Does Not Eliminate Tuberculosis Risk Under Anti-TNF Treatment in Inflammatory Bowel Disease: A Descriptive Study
    Abitbol, Yael
    Laharie, David
    Cosnes, Jacques
    Allez, Matthieu
    Nancey, Stephane
    Amiot, Aurelien
    Aubourg, Alexandre
    Fumery, Mathurin
    Altwegg, Romain
    Michetti, Pierre F.
    Chanteloup, Elise
    Seksik, Philippe
    Abitbol, Vered
    Baudry, Clotilde
    Flamant, Mathurin
    Bouguen, Guillaume
    Stefanescu, Carmen
    Bourrier, Anne
    Bommelaer, Gilles
    Dib, Nina
    Bigard, Andre
    Viennot, Stephanie
    Hebuterne, Xavier
    Gornet, Jean-Marc
    Marteau, Philippe R.
    Bouhnik, Yoram
    Nahon, Stephane
    GASTROENTEROLOGY, 2016, 150 (04) : S413 - S413
  • [38] Improved insulin sensitivity by anti-TNFα antibody treatment in patients with rheumatic diseases
    Huvers, Frank C.
    Popa, Calin
    Netea, Mihai G.
    van den Hoogen, Frank H. J.
    Tack, Cees J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (04) : 558 - 559
  • [39] Tuberculosis prophylaxis protocol used in patients with anti-TNF alpha treatment
    Guahnon, L
    Erra, A
    Moreno, E
    Tomas, C
    Pigrau, C
    Casellas, F
    Vidal, R
    Barcelo, P
    Marsal, S
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 405 - 405
  • [40] Tuberculosis incidence in Korean patients with rheumatic diseases under the treatment of infliximah, a TNF-α blocher.
    Joung, CI
    Kang, TY
    Lee, HS
    Uhm, WS
    Kim, TH
    Jun, JB
    Yoo, DH
    Kim, TY
    Bae, SC
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S562 - S563
12345